SCHEMBL4800291

SCHEMBL4800291

CCC(c1ccccc1)N1CC[N]CC1

nearest known ligand 0.56

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
OPRM1 P35372 6/20 0.56
OPRD1 P41143 6/20 0.56
OPRK1 P41145 6/20 0.56
OPRL1 P41146 6/20 0.56
MC4R P32245 3/20 0.46
CYP2D6 P10635 4/20 0.45
CYP1A2 P05177 3/20 0.45
CYP3A4 P08684 3/20 0.45
CYP2C19 P33261 3/20 0.45
TSHR P16473 1/20 0.45
SLC6A4 P31645 6/20 0.44
SLC6A2 P23975 3/20 0.44
CYP2C9 P11712 2/20 0.41
KCNA5 P22460 2/20 0.41
KCNH2 Q12809 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2962625 0.87 OPRM1 (0.65) OPRM1OPRD1OPRK1OPRL1MC4R
SCHEMBL3811836 0.83 OPRM1 (0.60) OPRM1OPRD1OPRK1OPRL1MC4R
SCHEMBL30363975 0.83 OPRM1 (0.61) OPRM1OPRD1OPRK1OPRL1MC4R
SCHEMBL30364119 0.83 OPRM1 (0.61) OPRM1OPRD1OPRK1OPRL1MC4R
SCHEMBL1964502 0.83 CYP1A2 (0.62) OPRM1OPRD1OPRK1OPRL1MC4R
SCHEMBL8916036 0.83 CYP1A2 (0.62) OPRM1OPRD1OPRK1OPRL1MC4R
SCHEMBL8922757 0.81 CYP1A2 (0.66) OPRM1OPRD1OPRK1OPRL1MC4R
SCHEMBL4334322 0.81 CYP1A2 (0.66) OPRM1OPRD1OPRK1OPRL1MC4R
SCHEMBL14593276 0.80 MC4R (0.69) OPRM1OPRD1OPRK1OPRL1MC4R
SCHEMBL3268419 0.79 SLC6A4 (0.68) OPRM1OPRD1OPRK1OPRL1CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7414048-B2 4,5-dihydro-isoxazole derivatives and their pharmaceutical use JANSSEN PHARMACEUTICA, N.V. (BE) 2008-08-19 US disclosed
US-6583141-B1 T cell mediated rheumatic diseases JANSSEN PHARMACEUTICA, N.V. (BE) 2003-06-24 US disclosed